S
Zodix
Study
Academic Library
Search
Shelves
Open access
Sign in
Search or jump to…
⌘K
John A. Wagner · Study
Home
/
Author
John A. Wagner
5 works
· latest 2016
· 2 institutions
cluster: provisional
ORCID 0000-0002-0636-5006
Follow
Suggest an ORCID correction
h-index
5
i10
5
Citations
226
Works here
5
06
10
16
Most cited in this library
A cost-effectiveness approach to the qualification and acceptance of biomarkers
2006 · 60 citations
Opening Up to Precompetitive Collaboration
2010 · 59 citations
The Biomarkers Consortium: Practice and Pitfalls of Open-Source Precompetitive Collaboration
2010 · 51 citations
Assessment of the Abuse Potential of the Orexin Receptor Antagonist, Suvorexant, Compared With Zolpidem in a Randomized Crossover Study
2016 · 42 citations
Encyclopedia of the Hundred Years War
2006 · 14 citations
Works
5 shown
Assessment of the Abuse Potential of the Orexin Receptor Antagonist, Suvorexant, Compared With Zolpidem in a Randomized Crossover Study
Journal of Clinical Psychopharmacology
·
2016
·
14 authors
42
citations
Opening Up to Precompetitive Collaboration
Science Translational Medicine
·
2010
·
10 authors
·
Open access
59
citations
The Biomarkers Consortium: Practice and Pitfalls of Open-Source Precompetitive Collaboration
Clinical Pharmacology & Therapeutics
·
2010
·
11 authors
51
citations
A cost-effectiveness approach to the qualification and acceptance of biomarkers
Nature Reviews Drug Discovery
·
2006
·
3 authors
·
review
60
citations
Encyclopedia of the Hundred Years War
Greenwood eBooks
·
2006
·
1 author
·
book
14
citations